AI Summary
✦ ClarthaColgate-Palmolive India is a personal and oral care manufacturer selling toothpastes, toothbrushes, mouthwash, soaps, cosmetics, and toiletries. Oral care remains central, while premium toothpaste sales online may support mix improvement and protect margins. Exports provide an additional revenue channel. Revenue declined 0.3%, while profit fell 7.8%; stable margins indicate weaker earnings mainly reflect subdued sales and operating leverage. ROE is unavailable, but debt/equity of 2.99 means leverage materially influences shareholder returns. At 41 times earnings, the stock appears rich relative to declining revenue and profit, despite positive sentiment. Premiumisation remains an upside question, while high leverage increases downside sensitivity.
Price Forecast
Probabilistic Range
Probabilistic lognormal cone using 1Y realized volatility and analyst-target drift when available.
Revenue Forecast
₹ CrEPS Forecast
₹ / shareMulti-factor synthesis of 5 key dimensions
From 26 analysts
Fundamentals
Fundamentals institutional score is 63 using growth durability 62.9.
Valuation
Valuation institutional score is 69 using relative multiple z-scores where peer dispersion is available.
Analyst Consensus
Analyst View institutional score is 49 using mean target upside 13.7%; dispersion penalty 13.6; recommendation breadth from available consensus.
Technical Structure
Technicals institutional score is 42 using EMA-20 continuation within 5% tolerance; VCP range/volume contraction proxy.
Market Sentiment
Recent news flow is balanced or not decisive enough to tilt the tape. Based on 3 recent ticker-linked news items.
Signal Summary
Market intelligence remains Neutral. valuation and market sentiment provide support, while analyst consensus and technical structure remain considerations.
Composite weights: Fundamentals 25%, Valuation 20%, Analyst Consensus 20%, Technical Structure 20%, Market Sentiment 15%.
Key Data Points
Important Note: This is market intelligence, not investment advice. Always conduct your own research and consider your financial goals and risk tolerance.
Valuation Metrics
Trading 13.8% below historical median. Valuation is declining — currently in the strongly undervalued zone (z-score: -0.95). Confidence: 83%.
Live forward EPS implies next-12-month EPS of ₹58.86. Applying the stock's normalized valuation corridor produces a fair range of ₹2,479.18 to ₹3,071.31, with base value near ₹2,760.53 (+37.9% vs current price).
Live forward estimate anchored to the company's historical valuation corridor.
Forward EPS
₹58.86
Forward P/E
34.0x
Base Fair Value
₹2,760.53
Fair Range
₹2,479.18 - ₹3,071.31
Upside To Base
+37.9%
Estimate Source
Live forward EPS
Growth Estimate
+7.0%
5Y Average
40.89
Current
40.41
Overvalued
52.18
Undervalued
42.12
5Y Average
28.82
Current
28.48
Overvalued
34.06
Undervalued
21.21
5Y Average
8.88
Current
8.77
Overvalued
10.49
Undervalued
6.53
Peers & Comparison
Sector: Consumer Staples · Theme: FMCG - Personal Products
| Company | Rev. Growth | Margin | P/E | vs Avg | 52W Perf. |
|---|---|---|---|---|---|
DABUR INDIA LTD DABURFMCG - Personal Products | +10.6% | 14.6% | 37.3x Fair | -12% vs avg | -17.6% |
GODREJ CONSUMER PRODUCTS GODREJCPFMCG - Personal Products | +15.4% | 12.1% | 56.9x Premium | +34% vs avg | -12.5% |
DR. REDDY S LABORATORIES DRREDDYPharmaceuticals | -5.6% | 10.0% | 29.5x Undervalued | -30% vs avg | -5.0% |
HINDALCO INDUSTRIES LTD HINDALCOMetals - Aluminium | +32.1% | 5.5% | 14.4x Undervalued | -66% vs avg | +58.0% |
GRASIM INDUSTRIES LTD GRASIMCement | +10.5% | 2.8% | 46.2x Fair | +9% vs avg | +23.4% |
EICHER MOTORS LTD EICHERMOTTrucks & Buses | +31.5% | 23.2% | 38.0x Fair | -10% vs avg | +41.7% |
BSE LIMITED BSEStock Exchanges & Ratings | +64.0% | 48.9% | 50.3x Premium | +19% vs avg | +50.1% |
APOLLO HOSPITALS ENTER. L APOLLOHOSPHospitals & Diagnostic Centres | +18.1% | 7.7% | 66.2x Premium | +56% vs avg | +23.2% |
COLGATE PALMOLIVE LTD. trades in line with peers (40.4x vs avg 42.4x), reflecting a fair valuation within the Fmcg - Personal Products cohort. Peers include DABUR INDIA LTD, GODREJ CONSUMER PRODUCTS, DR. REDDY S LABORATORIES — selected based on business model, industry classification, market cap similarity, and business theme alignment.
Financials
Real statement data for revenue, earnings quality, conversion, and balance-sheet coverage. Monetary values are shown in Rs crore.
Latest revenue
₹1.60K CrJun 2026Latest net profit
₹343 CrJun 2026Latest EPS
₹12.61Jun 2026Net margin
30.0%Jun 2026Performance
Bars show revenue and net profit. The line shows net margin.
- Revenue
- Net income
- Net margin %
Earnings
Revenue is shown in crores. EPS is rupees per share.
- Revenue
- EPS
Revenue to profit conversion
Bridge from operating numbers to profit for the latest reported period.
Latest reported period: Jun 2026
Debt level and coverage
Debt, cash and free cash flow compared on the same crore scale.
- Debt
- Free cash flow
- Cash & equivalents
Results
| Metric | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 1,324 | 1,471 | 1,396 | 1,490 | 1,497 | 1,619 | 1,462 | 1,463 | 1,434 | 1,520 | 1,486 | 1,595 | 1,603 |
| Expenses + | 906 | 989 | 927 | 958 | 988 | 1,122 | 1,007 | 964 | 981 | 1,054 | 1,044 | 1,086 | 1,120 |
| Operating Profit | 418 | 482 | 468 | 532 | 508 | 497 | 454 | 498 | 453 | 465 | 442 | 510 | 483 |
| OPM % | 32% | 33% | 34% | 36% | 34% | 31% | 31% | 34% | 32% | 31% | 30% | 32% | 30% |
| Other Income + | -5 | 21 | 18 | 23 | 23 | 76 | 20 | 19 | 18 | 15 | 31 | 0 | 19 |
| Interest | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 44 | 44 | 41 | 42 | 42 | 42 | 41 | 38 | 38 | 37 | 36 | 35 | 39 |
| Profit before tax | 369 | 458 | 443 | 511 | 489 | 530 | 433 | 478 | 432 | 442 | 436 | 474 | 462 |
| Tax % | 26% | 26% | 26% | 26% | 26% | 26% | 25% | 26% | 26% | 26% | 26% | 25% | 26% |
| Net Profit + | 274 | 340 | 330 | 380 | 364 | 395 | 323 | 355 | 321 | 328 | 324 | 353 | 343 |
| EPS in Rs | 10.06 | 12.50 | 12.14 | 13.96 | 13.38 | 14.52 | 11.87 | 13.05 | 11.79 | 12.04 | 11.91 | 12.99 | 12.61 |
| Raw PDF |
All values in ₹ Crores unless otherwise stated. Source: Screener Master (Standalone).
Events Timeline
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation